Education
About Us
Working with TipRanks
Follow Us
Hisamitsu Pharmaceutical Co (HTSUF)
:HTSUF
HTSUF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$21.04 - $34.59
Previous CloseN/A
Volume30.00
Average Volume (3M)3.00
Market Cap
$2.32B
Enterprise ValueN/A
Total Cash (Recent Filing)$116.64B
Total Debt (Recent Filing)¥2.93B
Price to Earnings (P/E)16.7
Beta0.23
Next Earnings
Jul 10, 2025EPS Estimate
0.47Last Dividend Ex-Date
Feb 27, 2025Dividend Yield1.81%
Share Statistics
EPS (TTM)1.94
Shares Outstanding85,164,894
10 Day Avg. Volume0
30 Day Avg. Volume3
Financial Highlights & Ratios
PEG Ratio2.76
Price to Book (P/B)1.15
Price to Sales (P/S)0.00
P/FCF Ratio-334.48
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Hisamitsu Pharmaceutical Co News
PremiumCompany Announcements
Hisamitsu Pharmaceutical Announces New Executive Appointments
PremiumCompany Announcements
Hisamitsu Pharmaceutical Announces Board of Directors Candidates
PremiumCompany Announcements
Hisamitsu Pharmaceutical Co. Reports Q2 GrowthPremiumPre-Earnings
Is HTSUF a Buy, Before Earnings?
PremiumCompany Announcements
Hisamitsu Pharma Reports Strong Q1 ResultsOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
2.44% Mutual Funds
― Other Institutional Investors
93.70% Public Companies and
Individual Investors
HTSUF FAQ
What was Hisamitsu Pharmaceutical Co ’s price range in the past 12 months?
Hisamitsu Pharmaceutical Co lowest stock price was $21.04 and its highest was $34.59 in the past 12 months.
What is Hisamitsu Pharmaceutical Co ’s market cap?
Hisamitsu Pharmaceutical Co ’s market cap is $2.32B.
When is Hisamitsu Pharmaceutical Co ’s upcoming earnings report date?
Hisamitsu Pharmaceutical Co ’s upcoming earnings report date is Jul 10, 2025 which is in 45 days.
How were Hisamitsu Pharmaceutical Co ’s earnings last quarter?
Hisamitsu Pharmaceutical Co released its earnings results on Jan 09, 2025. The company reported $0.432 earnings per share for the quarter, beating the consensus estimate of N/A by $0.432.
Is Hisamitsu Pharmaceutical Co overvalued?
According to Wall Street analysts Hisamitsu Pharmaceutical Co ’s price is currently Overvalued.
Does Hisamitsu Pharmaceutical Co pay dividends?
Hisamitsu Pharmaceutical Co pays a Semiannually dividend of $0.299 which represents an annual dividend yield of 1.81%. See more information on Hisamitsu Pharmaceutical Co dividends here
What is Hisamitsu Pharmaceutical Co ’s EPS estimate?
Hisamitsu Pharmaceutical Co ’s EPS estimate is 0.47.
How many shares outstanding does Hisamitsu Pharmaceutical Co have?
Hisamitsu Pharmaceutical Co has 85,164,894 shares outstanding.
What happened to Hisamitsu Pharmaceutical Co ’s price movement after its last earnings report?
Hisamitsu Pharmaceutical Co reported an EPS of $0.432 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 4.566%.
Which hedge fund is a major shareholder of Hisamitsu Pharmaceutical Co ?
Currently, no hedge funds are holding shares in HTSUF
Company Description
Hisamitsu Pharmaceutical Co
Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals, quasi-drugs, and medical devices in Japan. The company provides external pain relieving drugs under the SALONPAS, NOBINOBI, SALONSIP, AIR, SALONPAS, and FEITAS; and BUTENALOCK, a remedy for athlete's foot, as well as ALLEGRA FX, a sinus medication for allergies. It also manufactures and sells quasi-drugs and cosmetics; MOHRUS TAPE and MOHRUS PAP XR, transdermal analgesic anti-inflammatory drug; patches for female hormone, asthma treatment, and treatment for overactive bladders. In addition, the company manufactures and sells drugs under MOHRUS TAPE, MOHRUS PAP XR, FENTOS Tapes, NEOXY Tapes, Abstral, ALLESAGA Tapes, HARUROPI Tapes, and MENOAID Combipatch. Further, it provides HFT-290, a transdermal patch for cancer pain. The company sells its products in the United States and Asia. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan.
Technical Analysis
Sumitomo Dainippon Pharma Co
―
Torii Pharmaceutical Co
―
Tsumura & Co
―
Nippon Shinyaku Co., Ltd.
―
SAWAI GROUP HOLDINGS Co., Ltd.
―